Drug Shortage Report for HP-PAC

Last updated on 2017-10-17 History
Report ID 17360
Drug Identification Number 02238525
Brand name HP-PAC
Common or Proper name Lansoprazole, Clarithromycin, Amoxicillin
Company Name TAKEDA PHARMACEUTICALS AMERICA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) AMOXICILLIN LANSOPRAZOLE CLARITHROMYCIN
Strength(s) 500MG 30MG 500MG
Dosage form(s) KIT CAPSULE CAPSULE (SUSTAINED-RELEASE) TABLET
Route of administration ORAL
Packaging size HP-PAC 7-Day
ATC code A02BD
ATC description DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Reason for shortage Requirements related to complying with good manufacturing practices.
Anticipated start date
Actual start date 2017-09-21
Estimated end date 2017-10-13
Actual end date 2017-10-16
Shortage status Resolved
Updated date 2017-10-17
Company comments Resolved on Oct 16, 2017
Health Canada comments
Tier 3 Status No
Contact Address 95 HAYDEN AVENUE
LEXINGTON, MASSACHUSETTS
UNITED STATES 02421
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-07-26 English Compare
v2 2017-07-26 French Compare
v3 2017-08-01 English Compare
v4 2017-08-01 French Compare
v5 2017-08-10 English Compare
v6 2017-08-10 French Compare
v7 2017-08-29 English Compare
v8 2017-08-29 French Compare
v9 2017-09-27 English Compare
v10 2017-09-27 French Compare
v11 2017-10-16 English Compare
v12 2017-10-16 English Compare
v13 2017-10-16 French Compare
v14 2017-10-16 English Compare
v15 2017-10-16 French Compare
v16 2017-10-17 English Compare

Showing 1 to 16 of 16